![Heidi Henson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heidi Henson
Director/Board Member at
PERSPECTIVE THERAPEUTICS, INC.
Net worth: 71 431 $ as of 29/09/2026
Profile
Heidi Henson currently serves as Director at Cend Therapeutics, Inc. since 2019, Independent Director at Lisata Therapeutics, Inc. since 2022, Independent Director at Perspective Therapeutics, Inc. since 2023, Independent Non-Executive Director at PepGen Inc. since 2021, Independent Director at Korsana Biosciences, Inc. starting in 2026, and is a Member of The Association of Bioscience Financial Officers.
Former roles include Director-Finance at Anadys Pharmaceuticals, Inc., Principal at Fair Isaac Corp., Controller at La Jolla Pharmaceutical Co. from 2004 to 2005, Principal at HNC Software, Inc., Auditor at PricewaterhouseCoopers LLP, Chief Financial Officer & Secretary at Zeta Acquisition Corp.
III, Chief Financial Officer & Secretary at Araxes Pharma LLC from 2012 to 2018, Secretary, Chief Financial & Accounting Officer at Kura Oncology, Inc. from 2014 to 2018, Vice President-Finance at Intellikine LLC from 2011 to 2012, Chief Financial Officer & Secretary at Wellspring Biosciences LLC from 2012 to 2018, Chief Financial Officer at Imbria Pharmaceuticals, Inc. from 2019 to 2020, Chief Financial Officer at Respivant Sciences, Inc. from 2018 to 2019, Chief Financial Officer at Pardes Biosciences, Inc. from 2021 to 2023, and Chief Financial Officer at San Diego Children's Choir.
Education includes undergraduate studies at the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 25,975 ( 0.02% ) | 71 431 $ | 29/09/2026 | |
-.--% | 07/09/2026 | 0 ( -.--% ) | - $ | 29/09/2026 |
| 30/09/2026 | 0 ( -.--% ) | - $ | 29/09/2026 | |
PEPGEN INC. -.--% | 17/06/2026 | 0 ( -.--% ) | - $ | 29/09/2026 |
Heidi Henson active positions
| Companies | Position | Start |
|---|---|---|
| PEPGEN INC. | Director/Board Member | 30/06/2021 |
| LISATA THERAPEUTICS, INC. | Director/Board Member | 14/09/2022 |
| PERSPECTIVE THERAPEUTICS, INC. | Director/Board Member | 31/05/2023 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Director/Board Member | 30/01/2019 |
Former positions of Heidi Henson
| Companies | Position | End |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Director of Finance/CFO | 29/08/2023 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Director of Finance/CFO | 30/06/2020 |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases | Director of Finance/CFO | 31/03/2019 |
Araxes Pharma LLC
 Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and other diseases | Director of Finance/CFO | 30/06/2018 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Education of Heidi Henson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Fair Isaac Corp.
 Fair Isaac Corp. Financial Publishing/ServicesCommercial Services Provides business-to-business and consumer scoring & software services | Commercial Services |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
HNC Software, Inc.
 HNC Software, Inc. Packaged SoftwareTechnology Services Provides software solutions | Technology Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Araxes Pharma LLC
Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and other diseases | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
San Diego Children's Choir
 San Diego Children's Choir San Diego Children's Choir is a nonprofit choral training organization serving children ages 3 to 18 across multiple locations. The choir performs locally and on tours, collaborates with the San Diego Symphony, and participates in festivals and notable venues. The non-profit company is based in San Diego, CA. It provides music education and performance opportunities through programs such as an early childhood prelude program and sequential ensemble choirs for grades 1-12, with auditioned choirs starting in grade 4. Weekly rehearsals use creative methods like Orff and Kodaly, focusing on music literacy and healthy vocal technique, and are supported by professional musicians. Enrollment occurs twice yearly, with free auditions via Zoom, and tuition varies by choir level, including rehearsals, performances, and materials. Need-based scholarships and tuition-free instruction are available to over 70% of students, especially through outreach programs in underserved Title 1 schools, often in partnership with the Diamond Educational Excellence Partnership (DEEP). The organization relies on donations, grants, and fundraising for operational costs and scholarships, and encourages community involvement through volunteering, attending performances, and financial support. | |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Wellspring Biosciences LLC
 Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Health Technology |
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Respivant Sciences, Inc.
Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Lisata Therapeutics, Inc.
 Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
- Stock Market
- Insiders
- Heidi Henson
